Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diazepam dependence prevented by glutamate antagonists

K G Steppuhn1, L Turski

  • 1Research Laboratories of Schering AG, Berlin, Germany.

Proceedings of the National Academy of Sciences of the United States of America
|July 15, 1993
PubMed
Summary

Benzodiazepine withdrawal involves a silent phase and an active phase. AMPA antagonists prevent dependence signs during the silent phase, while NMDA antagonists are effective during the active phase.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiepileptic drugs and the developing brain.

Cellular and molecular life sciences : CMLS·2006
Same author

Glutamate antagonists limit tumor growth.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Neuronal death enhanced by N-methyl-D-aspartate antagonists.

Proceedings of the National Academy of Sciences of the United States of America·2000
Same author

Autoimmune encephalomyelitis ameliorated by AMPA antagonists.

Nature medicine·1999
Same author

N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain.

Proceedings of the National Academy of Sciences of the United States of America·1999
Same author

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

Science (New York, N.Y.)·1999

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurobiology

Background:

  • Long-term benzodiazepine use leads to tolerance and dependence.
  • Abrupt cessation of benzodiazepines triggers withdrawal symptoms like anxiety, seizures, and muscle rigidity.

Purpose of the Study:

  • To investigate the distinct roles of NMDA and non-NMDA mechanisms in benzodiazepine withdrawal.
  • To identify potential therapeutic targets for preventing benzodiazepine dependence.

Main Methods:

  • Mice underwent chronic diazepam treatment followed by abrupt discontinuation.
  • Withdrawal symptoms and seizure susceptibility were assessed during distinct phases (silent and active).
  • Mice were treated with NMDA antagonists (CPP) and AMPA antagonists (GYKI 52466) during different withdrawal phases.

Related Experiment Videos

Main Results:

  • A symptom-free 'silent phase' (days 1-3) showed enhanced non-NMDA receptor activity.
  • An 'active phase' (days 4-21) exhibited increased NMDA receptor-mediated seizures and reflexes.
  • AMPA antagonists prevented withdrawal signs during the silent phase; NMDA antagonists were effective during the active phase.

Conclusions:

  • NMDA-dependent mechanisms contribute to diazepam tolerance and withdrawal symptom expression.
  • The non-NMDA-mediated silent phase is crucial for triggering withdrawal symptoms.
  • AMPA antagonists represent a potential therapeutic strategy for preventing benzodiazepine dependence.